Compass Therapeutics develops specialized antibody treatments designed to block blood vessel growth in tumors and activate the immune system to fight cancer. Their current focus is on advancing several bispecific antibody candidates through clinical trials for various oncology applications. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
